2017
DOI: 10.5070/d3231033672
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous T-cell lymphoma-associated Leser-Trélat sign: report and world literature review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 12 publications
0
6
0
1
Order By: Relevance
“…In 1900, Hollander was the first to describe SQ in association with malignancy, but the names Leser and Trélat remained associated with the disease. 1,2,5,26 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In 1900, Hollander was the first to describe SQ in association with malignancy, but the names Leser and Trélat remained associated with the disease. 1,2,5,26 .…”
Section: Discussionmentioning
confidence: 99%
“…Leser-Trélat sign (TLS) is a rare paraneoplastic syndrome characterized by the sudden eruption of multiple seborrheic keratoses (QS) in patients with underlying malignancy [1][2][3][4][5][6][7][8][9][10][11][12][13] hidden or known 14 . These benign skin lesions rapidly increase in number and size over a period of weeks to months.…”
Section: Introductionmentioning
confidence: 99%
“…The LTS is most frequently associated with adenocarcinomas (gastrointestinal in 32% of cases), followed by lymphoproliferative disorders in 20% and, more rarely, with carcinomas of the breast, lung, liver, kidney, prostate, ovary, and nasopharynx [5]. In addition, mycosis fungoides, Sézary syndrome, and plasmacytoma have been described in association with this paraneoplastic disorder [6].…”
Section: Sirmentioning
confidence: 99%
“…A careful search for an underlying malignancy should be undertaken. A physical examination with a complete blood count, serum biochemistry, chest X-ray, mammogram, Pap smear, PSA screening, upper GI endoscopy, and colonoscopy is required during this examination [5][6][7].…”
Section: Case Lettermentioning
confidence: 99%
“…Возраст пациентов с СЛТ может быть различным, однако средний возраст появления данного синдрома составляет около 61 года. Сообщения о связи СЛТ с полом или какой-либо расой отсутствуют [22]. Особую онконастороженность должны вызывать пациенты молодого возраста, которым не свойственен сенильный кератоз.…”
Section: синдром лезера-треля (Sign Leser-trélat)unclassified